bortezomib,lenalidomide,dexamethasone,daratumumab
janssen,takeda
at #ims2022, we're presenting our latest data in newly diagnosed #multiplemyeloma.
Official Twitter site of JanssenUS, to inform media about company news.  Tweets by our communications team. Review our guidelines here: https://t.co/WrVM19L6Yn